Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annabelle Biscans

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry|August 12, 2015
Synthesis, binding, nuclease resistance and cellular uptake properties of 2'-O-acetalester-modified oligonucleotides containing cationic groupsAnnabelle Biscans, Sonia Rouanet, Jean-Rémi Bertrand, et al.
Nature Reviews. Nephrology|October 9, 2025
RNA-based therapeutic opportunities for the treatment of kidney diseasesJurriën Prins, Annabelle Biscans, Anton Jan van Zonneveld, et al.
Chembiochem : a European Journal of Chemical Biology|October 28, 2014
Direct synthesis of partially modified 2'-O-pivaloyloxymethyl RNAs by a base-labile protecting group strategy and their potential for prodrug-based gene-silencing applicationsAnnabelle Biscans, Maxence Bos, Anthony R Martin, et al.
Chembiochem : a European Journal of Chemical Biology|August 30, 2016
Lipophilic 2'-O-Acetal Ester RNAs: Synthesis, Thermal Duplex Stability, Nuclease Resistance, Cellular Uptake, and siRNA Activity after Spontaneous Naked DeliveryAnnabelle Biscans, Jean-Rémi Bertrand, Josephine Dubois, et al.
Molecular Therapy. Nucleic Acids|December 20, 2019
Hydrophobically Modified let-7b miRNA Enhances Biodistribution to NSCLC and Downregulates HMGA2 In VivoMeirav Segal, Annabelle Biscans, Maud-Emmanuelle Gilles, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 28, 2018
Hydrophobicity of Lipid-Conjugated siRNAs Predicts Productive Loading to Small Extracellular VesiclesAnnabelle Biscans, Reka A Haraszti, Dimas Echeverria, et al.
Molecular Therapy. Methods & Clinical Development|July 17, 2025
A systemically deliverable lipid-conjugated siRNA targeting DUX4 as an facioscapulohumeral muscular dystrophy therapeuticKatelyn Daman, Jing Yan, Annabelle Biscans, et al.
RNA Biology|February 21, 2022
Innovative developments and emerging technologies in RNA therapeuticsFrançois Halloy, Annabelle Biscans, Katherine E Bujold, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Single intravitreal administration of a tetravalent siRNA exhibits robust and efficient gene silencing in rodent and swine photoreceptorsShun-Yun Cheng, Jillian Caiazzi, Annabelle Biscans, et al.
Nucleic Acid Therapeutics|October 13, 2017
Pharmacokinetic Profiling of Conjugated Therapeutic Oligonucleotides: A High-Throughput Method Based Upon Serial Blood Microsampling Coupled to Peptide Nucleic Acid Hybridization AssayBruno M D C Godinho, James W Gilbert, Reka A Haraszti, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry|August 12, 2015
Synthesis, binding, nuclease resistance and cellular uptake properties of 2'-O-acetalester-modified oligonucleotides containing cationic groupsAnnabelle Biscans, Sonia Rouanet, Jean-Rémi Bertrand, et al.
Nature Reviews. Nephrology|October 9, 2025
RNA-based therapeutic opportunities for the treatment of kidney diseasesJurriën Prins, Annabelle Biscans, Anton Jan van Zonneveld, et al.
Chembiochem : a European Journal of Chemical Biology|October 28, 2014
Direct synthesis of partially modified 2'-O-pivaloyloxymethyl RNAs by a base-labile protecting group strategy and their potential for prodrug-based gene-silencing applicationsAnnabelle Biscans, Maxence Bos, Anthony R Martin, et al.
Chembiochem : a European Journal of Chemical Biology|August 30, 2016
Lipophilic 2'-O-Acetal Ester RNAs: Synthesis, Thermal Duplex Stability, Nuclease Resistance, Cellular Uptake, and siRNA Activity after Spontaneous Naked DeliveryAnnabelle Biscans, Jean-Rémi Bertrand, Josephine Dubois, et al.
Molecular Therapy. Nucleic Acids|December 20, 2019
Hydrophobically Modified let-7b miRNA Enhances Biodistribution to NSCLC and Downregulates HMGA2 In VivoMeirav Segal, Annabelle Biscans, Maud-Emmanuelle Gilles, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 28, 2018
Hydrophobicity of Lipid-Conjugated siRNAs Predicts Productive Loading to Small Extracellular VesiclesAnnabelle Biscans, Reka A Haraszti, Dimas Echeverria, et al.
Molecular Therapy. Methods & Clinical Development|July 17, 2025
A systemically deliverable lipid-conjugated siRNA targeting DUX4 as an facioscapulohumeral muscular dystrophy therapeuticKatelyn Daman, Jing Yan, Annabelle Biscans, et al.
RNA Biology|February 21, 2022
Innovative developments and emerging technologies in RNA therapeuticsFrançois Halloy, Annabelle Biscans, Katherine E Bujold, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Single intravitreal administration of a tetravalent siRNA exhibits robust and efficient gene silencing in rodent and swine photoreceptorsShun-Yun Cheng, Jillian Caiazzi, Annabelle Biscans, et al.
Nucleic Acid Therapeutics|October 13, 2017
Pharmacokinetic Profiling of Conjugated Therapeutic Oligonucleotides: A High-Throughput Method Based Upon Serial Blood Microsampling Coupled to Peptide Nucleic Acid Hybridization AssayBruno M D C Godinho, James W Gilbert, Reka A Haraszti, et al.
Pageof 4